Bergkvist, R. , and Svärd. P.O.: Studies on the thrombolytic activity of a protease from Aspergillus oryzae. Acta physiol. scand., 60: 363, 1964.
2.
Bergström, K. , Blombäck, B., and Kleen, G.: Studies on the plasma fibrinolytic activity in a case of liver cirrhosis. Acta med. scand., 168: 291, 1960.
3.
Blombäck, M. , Blombäck, B., Olsson , P.I., and Svendsen , L.: Assay of thrombin-like enzymes and its inhibitors with a synthetic peptide substrate. VI Int. Congr . Thrombosis and Haemostasis, Vienna1973.
4.
Ekeström, S., Frisch, E.P., Lund, F., and Magaard, F.: Brinase treatment of advanced peripheral arterial disease. 1975. To be published.
5.
Fagerhol, M.K. , and Abildgaard, U.: Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum-concentration . Scand. J. Haemat., 7: 10, 1970.
6.
Freedman, H.J. , and Roschlau, W.H.E.: Some factors influencing the toxicity of thrombolytic enzvmes (brinase). Canad. J. Phvsiol. Pharmacol. , 48: 69, 1970.
7.
Frisch, E.P., and Kiessling, H.: Dosage of iv brinase based on determination of brinase inhibitor capacity. 1975. To be published.
8.
Godal, H.C., and Abildgaard, U.: Gelation of soluble fibrin in plasma by ethanol. Scand. J. Haemat., 3: 342, 1966.
9.
Jürgens, J., Lindvall, S., Magnusson, O., and Orth, K.: Inhibitors in plasma from man treated with a protease from Asperigillus oryzae . Acta physiol. scand., 78: 11, 1970.
10.
Kiessling, H.: Determination of brinase inhibitors in plasma in plasma by use of azocollagen as a substrate. 1974. To be published.
11.
Kiessling, H., and Frisch, E.P.: Activity and immunological reactivity of brinase inhibitors in human plasma . 1975. To be published.
12.
Kiessling, H., and Svensson, R.: Influence of an enzyme from Aspergillus oryzae, Protease I. on some components of the fibrinolytic system. Acta chem. scand., 24: 569, 1970.
13.
Lund, F., Ekeström, S., Frisch, E.P., and Magaard, F.: Thrombolytic treatment with brinase of advanced arterial obliterative disease of the limbs. Angiology (Balt), 26: 534, 1975.
14.
Mancini, G. , Carbonara, A.O., and Heremans , J.F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Int. J. Immunochem ., 2: 235, 1965.
15.
Merskey. C. , Kleiner, G.J., and Johnson, A.J.: Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood.28: 1, 1966.
16.
Nilsson, I.M. , Blomback, M., and von Francken , I.: On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand., 159: 35, 1957.
17.
Noren, I.: Specific assay of prothrombin. A method using a freeze-dried reagent of intrinsic coagulation factors. Scand. J. clin. Lab. Invest. , 25: 47, 1970.
18.
Nyman, D.: Aktiverad partiell tromboplastintid vid diagnostik av koagulationsrubbningar. (Actived partial thromboplastin time in diagnosing coagulation disturbances.)Lakartidningen, 70: 3241, 1973.
19.
Owren, P.A. : Thrombotest. A new method for controlling anticoagulant therapy. Lancet, 2: 754, 1959.
Roschlau, W.H.E. : Thrombolytic properties and side effects of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the dog. J. clin. Path., 25: 635, 1972
22.
Vermylen, C. , de Vreker, R.A., and Verstraete , M.: A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT-test) . Clin. chim. Acta, 8: 418, 1963.
23.
Wolf, P.: A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma. J. clin. Path. , 6: 34, 1953.